×

Randomized trial of botulinum toxin to prevent pes cavus progression in pediatric charcot-marie-tooth disease type 1A: Burns J et al.

Musscle Nerve  42: 262–267, 2010
JOSHUA BURNS, PhD, 1,2
ADAM SCHEINBERG, MMed, 3,4
MONIQUE M. RYAN, MMed, 5
KRISTY J. ROSE, MHSc, 2
and ROBERT A. OUVRIER, MD, 2
Faculty of Health Sciences, University of Sydney, Sydney, New South Wales, Australia 
Institute for Neuroscience and Muscle Research, Children’s Hospital at Westmead, Locked Bag 4001, Sydney,New South Wales 2145, Australia 
Department of Rehabilitation, The Children’s Hospital at Westmead, Sydney, New South Wales, Australia 
 Victorian Paediatric Rehabilitation Service, Victoria, Australia 
Children’s Neuroscience Centre, Royal Children’s Hospital/Murdoch Children’s Research Institute/Department of Paediatrics,Faculty of Medicine, University of Melbourne, Victoria, Australia

Bitte hier klicken!